Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Nov 15, 2019
WCVB Channel 5
“The team at FDNA in Boston are like detectives, using facial recognition technology to help clinicians diagnose patients faster. It’s the same technology used by Facebook to tag people in photos.”
The article from WCVB.com states that FDNA’s Face2Gene technology is revolutionizing the detection of genetic disorders through facial recognition. Face2Gene employs advanced AI algorithms to analyze facial features and identify anomalies associated with various genetic conditions. The tool quickly and accurately suggests potential diagnoses by comparing patient photos to a vast database. This technology helps doctors in early detection and intervention, significantly improving patient outcomes. FDNA’s innovations highlight the transformative potential of AI in healthcare, making genetic disorder diagnosis more efficient and accessible.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…